Table 3. Log predicted remimazolam concentration in SP and LPF(-) groups.
Variables | SP | LPF(-) | P value |
---|---|---|---|
Patients, n | 34 | 15 | |
At the end of remimazolam infusion, log M | -6.33 (-6.44—-6.21) | -6.44 (-6.53—-6.30) | 0.112 |
At the end of extubation, log M | -6.61 (-6.74—-6.45) | -6.85 (-6.95—-6.76) | 0.000 * |
Difference of concentration, log M | 0.26 (0.21–0.33) | 0.41 (0.33–0.47) | 0.000 * |
Data are median (IQR; 25% ‒ 75% interquartile range).
*significant difference.
SP, short period (time to extubation < 15 min); LPF(-), long period (time to extubation ≥ 15 min) without flumazenil.